Acadian Asset Management LLC Checkpoint Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$2.19 - $2.96 $174,523 - $235,885	-79,691 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$1.62 - $4.24 $57,247 - $149,833	-35,338 Reduced 30.72%	79,691 $214,000
Q2 2020 Aug 12, 2020	SELL	$1.19 - $2.27 $6,258 - $11,937	-5,259 Reduced 4.37%	115,029 $227,000
Q1 2020 May 11, 2020	BUY	$1.11 - $2.43 $37,927 - $83,030	34,169 Added 39.68%	120,288 $182,000
Q4 2019 Feb 06, 2020	BUY	$1.18 - $2.39 $60,608 - $122,757	51,363 Added 147.78%	86,119 $148,000
Q3 2019 Nov 07, 2019	BUY	$2.15 - $3.36 $15,153 - $23,681	7,048 Added 25.44%	34,756 $87,000
Q2 2019 Aug 08, 2019	BUY	$2.75 - $5.0 $76,197 - $138,540	27,708 New	27,708 $84,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $281M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.